Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV001311279 | SCV001501388 | pathogenic | not provided | 2021-01-01 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000154199 | SCV000203851 | drug response | Tyrosine kinase inhibitor response | 2007-01-16 | no assertion criteria provided | clinical testing | |
Key Laboratory of Carcinogenesis and Cancer Invasion, |
RCV003998240 | SCV004042728 | likely pathogenic | Lung adenocarcinoma | no assertion criteria provided | clinical testing |